Centrus Energy: Earnings Beat, Cash Flow Negative
Centrus Energy reported consecutive earnings beats of 288.9% and 118.5% above consensus with a $4.5 billion order backlog. Yet trailing free cash flow sits at negative $127 million, and the stock has
69% Selloff Tests Centrus's $4.5B Backlog Case
NEW YORK, October 13 —
The income statement and the cash account at Centrus Energy Corp. (LEU) are telling different stories. Two consecutive earnings surprises, 288.9% and 118.5%, and a $4.5 billion order backlog make the case for a turning uranium enrichment cycle; trailing free cash flow of negative $127 million and a 69% stock decline from last October's peak argue the economics have not yet followed.
- Two straight EPS beats: 118.5% above consensus in the latest reported quarter, 288.9% the prior, per the August 5 earnings filing.
- Trailing FCF negative $127 million; stock has declined roughly 69% from its $464.25 October 2025 high.
- Short interest at 30.3% of the float; $4.5 billion LEU and HALEU backlog as of Q2 2026.
Earnings Growth Without Cash Generation
Centrus runs two segments: the LEU segment sells separative work units and enriched uranium products to nuclear utilities in the U.S., Japan, and the Netherlands; the Technical Solutions arm provides engineering and manufacturing services. The company is also the only publicly traded U.S. producer of high-assay low-enriched uranium, the fuel next-generation reactors require. It shut commercial-scale enrichment plants approximately 13 years ago when importing overseas LEU was cheaper, then reversed course after U.S. sanctions on Russia reset the market. Revenue grew 14% year over year to $470 million trailing, but operating cash flow of negative $55 million shows restart investments are front-loaded and cash conversion may take years.
The Raise That Raised More Questions
In a two-day window in September, Centrus priced an equity offering, evidenced by 424B5 prospectus supplements filed September 9 and September 11, while simultaneously filing an 8-K disclosing a Material Definitive Agreement. News reports identify the September 11 deal as a HALEU supply contract with Antares, a next-generation reactor developer. The pairing reads two ways: the company secured a commercial anchor for the raise, or it needed fresh equity at a stock price far below the prior-year high because the cash generation gap left limited options. Institutional investors hold 89.4% of shares; short interest sits at 30.3% of the float, split between those betting on near-term cash improvement and those who are not.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| LEU | $2.7B | 35.1x | -65.8% |
| SMR | $2.7B | n/a | -85.4% |
| NNE | $771M | n/a | -73.7% |
| OKLO | $5.9B | n/a | -81.5% |
| BWXT | $12.7B | 26.5x | -30.9% |
| UUUU | $2.5B | 19.1x | -63.2% |
When Backlog Converts to Cash
The near-term test is whether free cash flow improves. Centrus holds $1.87 billion in cash against $1.18 billion in debt, a net cash position of roughly $690 million that funds the HALEU production ramp and the planned restart of low-enriched uranium enrichment at its Ohio facility, targeted by decade's end. The forward P/E of 35.7x and a consensus analyst price target of $240.82, implying roughly 79% upside from current levels, both depend on that cash conversion arriving; readers can stress-test those assumptions with the DCF calculator. Whether FCF narrows materially in the next quarterly report is the clearest near-term signal. Run the free Centrus Energy Corp. deep-dive →
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
Why is Centrus Energy stock down 69% with strong earnings?
Centrus Energy reported consecutive EPS beats of 288.9% and 118.5%, yet trailing free cash flow remains negative at $127 million. The stock's 69% decline from its October 2025 peak suggests investors are skeptical about when the company's $4.5 billion backlog will convert to positive cash generation, which would justify the current forward P/E of 35.7x.
What is Centrus Energy's $4.5 billion backlog?
Centrus holds $4.5 billion in orders for LEU and HALEU, which is the fuel next-generation reactors require. In September 2026, the company announced a HALEU supply contract with Antares, a next-generation reactor developer.
Is Centrus Energy's cash flow positive?
No, trailing free cash flow is negative $127 million. Operating cash flow is also negative at $55 million, as restart investments are front-loaded. The company holds $1.87 billion in cash against $1.18 billion in debt, a net cash position of roughly $690 million.
What is the analyst price target for Centrus Energy?
The consensus analyst price target is $240.82, implying roughly 79% upside from current levels. The stock's current forward P/E is 35.7x, which reflects investor expectations that free cash flow will improve as the company ramps HALEU production and restarts low-enriched uranium enrichment at its Ohio facility, targeted by decade's end.
When will Centrus Energy's backlog convert to cash?
The company holds a net cash position of $690 million, providing runway for the HALEU production ramp and the planned restart of low-enriched uranium enrichment at its Ohio facility, targeted by decade's end. The clearest near-term signal will be whether free cash flow improves materially in the next quarterly report.
Centrus Energy has posted consecutive earnings beats of 289% and 119% and grown its backlog to $4.5 billion, yet the stock has shed 69% from its October 2025 high while free cash flow remains deeply negative — a gap the company's September equity offering widened rather than resolved.